Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue

Jun Yin, Jong Han Lee, Jin Zhang, Zhanguo Gao, Vsevolod Polotsky, Jianping Ye

Research output: Contribution to journalArticle

Abstract

Hepatocyte growth factor (HGF) is expressed as an angiogenic factor in adipose tissue. However, the molecular mechanism of Hgf expression remains largely unknown in the tissue. We addressed the issue by studying Hgf expression in adipocytes and macrophages. Hgf was expressed more in the stromal-vascular fraction than the adipocyte fraction. The expression was fivefold more in macrophages than the stromal-vascular faction and was reduced by 50% after macrophage deletion in adipose tissue. The expression was reduced by differentiation in adipocytes and by tumor necrosis factor-α or lipopolysaccharide treatment in macrophages. The expression was suppressed by nuclear factor (NF)-κB in C57BL/6 mice with NF-κB p65 overexpression under the aP2 gene promoter (aP2-p65 mice) but enhanced by inactivation of NF-κB p65 in mouse embryonic fibroblasts. The Hgf gene promoter was suppressed by p65 overexpression, which blocked peroxisome proliferator-activated receptor-γ (PPARγ) interaction with RNA polymerase II. The p65 activity was abolished by knockdown of histone deacetylase 3. Hgf expression was upregulated by hypoxia in vitro and in vivo. Compared with vascular endothelial growth factor (Vegf), which was predominately expressed in mature adipocytes, Hgf was mainly expressed in nonadipocytes, suggesting that Hgf and Vegf may have different cell sources in adipose tissue. In mechanism, Hgf expression is inhibited by NF-κB through suppression of PPARγ function in the Hgf gene promoter. Both Hgf and Vegf are induced by hypoxia. The study provides a molecular mechanism for the difference of inflammation and hypoxia in the regulation of angiogenic factors.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume306
Issue number8
DOIs
StatePublished - Apr 15 2014

Fingerprint

Peroxisome Proliferator-Activated Receptors
Hepatocyte Growth Factor
Adipocytes
Adipose Tissue
Macrophages
Vascular Endothelial Growth Factor A
Angiogenesis Inducing Agents
Blood Vessels
Genes
RNA Polymerase II
Inbred C57BL Mouse
Lipopolysaccharides
Tumor Necrosis Factor-alpha
Fibroblasts
Inflammation
Hypoxia

Keywords

  • Adipose tissue hypoxia
  • Inflammation
  • Macrophage infiltration
  • Mice with nuclear factor-κB p65 overexpression under the Ap2 gene promoter
  • Nuclear factor-κB
  • Peroxisome proliferator-activated receptorγ
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue. / Yin, Jun; Lee, Jong Han; Zhang, Jin; Gao, Zhanguo; Polotsky, Vsevolod; Ye, Jianping.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 306, No. 8, 15.04.2014.

Research output: Contribution to journalArticle

@article{28c7eb1d43554c6ebd393c16e0fd8e2d,
title = "Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue",
abstract = "Hepatocyte growth factor (HGF) is expressed as an angiogenic factor in adipose tissue. However, the molecular mechanism of Hgf expression remains largely unknown in the tissue. We addressed the issue by studying Hgf expression in adipocytes and macrophages. Hgf was expressed more in the stromal-vascular fraction than the adipocyte fraction. The expression was fivefold more in macrophages than the stromal-vascular faction and was reduced by 50{\%} after macrophage deletion in adipose tissue. The expression was reduced by differentiation in adipocytes and by tumor necrosis factor-α or lipopolysaccharide treatment in macrophages. The expression was suppressed by nuclear factor (NF)-κB in C57BL/6 mice with NF-κB p65 overexpression under the aP2 gene promoter (aP2-p65 mice) but enhanced by inactivation of NF-κB p65 in mouse embryonic fibroblasts. The Hgf gene promoter was suppressed by p65 overexpression, which blocked peroxisome proliferator-activated receptor-γ (PPARγ) interaction with RNA polymerase II. The p65 activity was abolished by knockdown of histone deacetylase 3. Hgf expression was upregulated by hypoxia in vitro and in vivo. Compared with vascular endothelial growth factor (Vegf), which was predominately expressed in mature adipocytes, Hgf was mainly expressed in nonadipocytes, suggesting that Hgf and Vegf may have different cell sources in adipose tissue. In mechanism, Hgf expression is inhibited by NF-κB through suppression of PPARγ function in the Hgf gene promoter. Both Hgf and Vegf are induced by hypoxia. The study provides a molecular mechanism for the difference of inflammation and hypoxia in the regulation of angiogenic factors.",
keywords = "Adipose tissue hypoxia, Inflammation, Macrophage infiltration, Mice with nuclear factor-κB p65 overexpression under the Ap2 gene promoter, Nuclear factor-κB, Peroxisome proliferator-activated receptorγ, Vascular endothelial growth factor",
author = "Jun Yin and Lee, {Jong Han} and Jin Zhang and Zhanguo Gao and Vsevolod Polotsky and Jianping Ye",
year = "2014",
month = "4",
day = "15",
doi = "10.1152/ajpendo.00687.2013",
language = "English (US)",
volume = "306",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "8",

}

TY - JOUR

T1 - Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue

AU - Yin, Jun

AU - Lee, Jong Han

AU - Zhang, Jin

AU - Gao, Zhanguo

AU - Polotsky, Vsevolod

AU - Ye, Jianping

PY - 2014/4/15

Y1 - 2014/4/15

N2 - Hepatocyte growth factor (HGF) is expressed as an angiogenic factor in adipose tissue. However, the molecular mechanism of Hgf expression remains largely unknown in the tissue. We addressed the issue by studying Hgf expression in adipocytes and macrophages. Hgf was expressed more in the stromal-vascular fraction than the adipocyte fraction. The expression was fivefold more in macrophages than the stromal-vascular faction and was reduced by 50% after macrophage deletion in adipose tissue. The expression was reduced by differentiation in adipocytes and by tumor necrosis factor-α or lipopolysaccharide treatment in macrophages. The expression was suppressed by nuclear factor (NF)-κB in C57BL/6 mice with NF-κB p65 overexpression under the aP2 gene promoter (aP2-p65 mice) but enhanced by inactivation of NF-κB p65 in mouse embryonic fibroblasts. The Hgf gene promoter was suppressed by p65 overexpression, which blocked peroxisome proliferator-activated receptor-γ (PPARγ) interaction with RNA polymerase II. The p65 activity was abolished by knockdown of histone deacetylase 3. Hgf expression was upregulated by hypoxia in vitro and in vivo. Compared with vascular endothelial growth factor (Vegf), which was predominately expressed in mature adipocytes, Hgf was mainly expressed in nonadipocytes, suggesting that Hgf and Vegf may have different cell sources in adipose tissue. In mechanism, Hgf expression is inhibited by NF-κB through suppression of PPARγ function in the Hgf gene promoter. Both Hgf and Vegf are induced by hypoxia. The study provides a molecular mechanism for the difference of inflammation and hypoxia in the regulation of angiogenic factors.

AB - Hepatocyte growth factor (HGF) is expressed as an angiogenic factor in adipose tissue. However, the molecular mechanism of Hgf expression remains largely unknown in the tissue. We addressed the issue by studying Hgf expression in adipocytes and macrophages. Hgf was expressed more in the stromal-vascular fraction than the adipocyte fraction. The expression was fivefold more in macrophages than the stromal-vascular faction and was reduced by 50% after macrophage deletion in adipose tissue. The expression was reduced by differentiation in adipocytes and by tumor necrosis factor-α or lipopolysaccharide treatment in macrophages. The expression was suppressed by nuclear factor (NF)-κB in C57BL/6 mice with NF-κB p65 overexpression under the aP2 gene promoter (aP2-p65 mice) but enhanced by inactivation of NF-κB p65 in mouse embryonic fibroblasts. The Hgf gene promoter was suppressed by p65 overexpression, which blocked peroxisome proliferator-activated receptor-γ (PPARγ) interaction with RNA polymerase II. The p65 activity was abolished by knockdown of histone deacetylase 3. Hgf expression was upregulated by hypoxia in vitro and in vivo. Compared with vascular endothelial growth factor (Vegf), which was predominately expressed in mature adipocytes, Hgf was mainly expressed in nonadipocytes, suggesting that Hgf and Vegf may have different cell sources in adipose tissue. In mechanism, Hgf expression is inhibited by NF-κB through suppression of PPARγ function in the Hgf gene promoter. Both Hgf and Vegf are induced by hypoxia. The study provides a molecular mechanism for the difference of inflammation and hypoxia in the regulation of angiogenic factors.

KW - Adipose tissue hypoxia

KW - Inflammation

KW - Macrophage infiltration

KW - Mice with nuclear factor-κB p65 overexpression under the Ap2 gene promoter

KW - Nuclear factor-κB

KW - Peroxisome proliferator-activated receptorγ

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84900530792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900530792&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00687.2013

DO - 10.1152/ajpendo.00687.2013

M3 - Article

VL - 306

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 8

ER -